2269 — WuXi Biologics (Cayman) Share News
0.000.00%
Last trade - 00:00- HK$198.43bn
- HK$193.91bn
- CNY21.79bn
Brief: WuXi Biologics Announces Acquisition Of 30% Equity Interest In Wuxi Vaccines
Brief: Wuxi Biologics Posts HY Net Profit Attributable Of RMB1,499.1 Mln
Brief: WuXi Biologics Posts H1 Gross Profit RMB3,350 Million
Brief: Blackrock's Long Position In Wuxi Biologics Increases To 5.23% On Aug 2 - HKEX
China's WuXi Biologics hits near 3-week peak after shares buyback
China stocks rise as industrial profits grow; energy, semiconductor shares lead gains
WuXi Biologics falls on US security risk concerns
Brief: Wuxi Biologics Noted Meeting On, Among Others, Revised Version Of Draft Bill
US House committee voices support for bill to restrict BGI, WuXi AppTec (updated)
US House committee advances bill to restrict BGI, WuXi AppTec (updated)
US House panel advances legislation restricting business with Chinese biotech firms
WuXi AppTec's Hong Kong shares jump as US bill to give more time to cut ties
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties (updated)
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties
Fujifilm to invest $1.2 bln in North Carolina plant in biopharma expansion (updated)
Brief: HKEX Says Blackrock's Long Position In Wuxi Biologics Decreases To 4.64%
Brief: WuXi Biologics Announces FY Revenue Of RMB17,034.3 Mln
Brief: Wuxi Biologics Posts FY Profit Attributable Of RMB3,399.7 Mln
Brief: JPMorgan Chase & Co's Long Position In Wuxi Biologics Increases To 6.27% - HKEX